STAT3h
The science behind Summit’s success, 23andMe’s fate, and more biotech news updates
Amgen's immunology drug results —The Novo Nordisk Senate hearing —Sanofi's soul-searching Read on to learn more.
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
SUNNYVALE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health ...
Turmoil strikes 23andMe as board members resign in dispute with founder
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...
Rolling Out1d
23andMe’s board resignation: Money problems and ties to the Black community
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...
Business Insider on MSN6d
Read the memo 23andMe's cofounder sent to staff after the entire board quit
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
What happened to 23andMe?
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
23andMe agrees to $30 million settlement over data breach that affected 6.9 million users
Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.
23andMe Comments on Emotional Eating
Me Holding Co., (NASDAQ: ME) shares squeaked ahead mid-week Wednesday. The company, a leading human genetics and preventive health concern, today released a new report on the genetics of emotional ...
This Genomics Company Says It's Considering Acquiring 23andMe
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...